| Primary |
| Hepatitis B |
50.3% |
| Chronic Hepatitis B |
25.7% |
| Product Used For Unknown Indication |
4.7% |
| Pyrexia |
3.5% |
| Chronic Hepatitis |
1.8% |
| Diarrhoea |
1.8% |
| Hepatic Cirrhosis |
1.8% |
| Hiv Infection |
1.8% |
| Liver Injury |
1.8% |
| Pain |
1.8% |
| Diabetes Mellitus |
1.2% |
| Antiviral Prophylaxis |
0.6% |
| Diuretic Therapy |
0.6% |
| Gastrooesophageal Reflux Disease |
0.6% |
| Hepatitis B Virus |
0.6% |
| Insomnia |
0.6% |
| Promotion Of Peripheral Circulation |
0.6% |
| Prophylaxis |
0.6% |
|
| Viral Load Increased |
14.1% |
| Hepatic Failure |
8.5% |
| Drug Ineffective |
7.0% |
| Osteomalacia |
7.0% |
| Vitamin D Decreased |
7.0% |
| Weight Decreased |
7.0% |
| Hepatocellular Carcinoma |
5.6% |
| Varices Oesophageal |
5.6% |
| Alanine Aminotransferase Increased |
4.2% |
| No Adverse Event |
4.2% |
| Oesophageal Varices Haemorrhage |
4.2% |
| Haemolytic Anaemia |
2.8% |
| Hepatic Enzyme Increased |
2.8% |
| Hypophosphataemia |
2.8% |
| Melaena |
2.8% |
| Myocardial Infarction |
2.8% |
| Myopathy Toxic |
2.8% |
| Nephropathy |
2.8% |
| Pneumonia |
2.8% |
| Renal Impairment |
2.8% |
|
| Secondary |
| Hepatitis B |
56.0% |
| Chronic Hepatitis B |
15.4% |
| Hepatic Cirrhosis |
14.3% |
| Diabetes Mellitus |
5.5% |
| Breast Cancer |
2.2% |
| Viral Infection |
2.2% |
| Antiviral Prophylaxis |
1.1% |
| Hypertension |
1.1% |
| Liver Disorder |
1.1% |
| Metastases To Bone |
1.1% |
|
| Drug Ineffective |
12.8% |
| Viral Load Increased |
12.8% |
| Hepatitis B |
10.3% |
| Oesophageal Varices Haemorrhage |
10.3% |
| Ascites |
5.1% |
| Hepatic Failure |
5.1% |
| Renal Failure |
5.1% |
| Renal Impairment |
5.1% |
| Viral Mutation Identified |
5.1% |
| Bone Pain |
2.6% |
| Foetal Exposure During Pregnancy |
2.6% |
| Haematemesis |
2.6% |
| Heart Disease Congenital |
2.6% |
| Hypoglycaemia |
2.6% |
| Hypokalaemia |
2.6% |
| Hypophosphataemia |
2.6% |
| Rash Maculo-papular |
2.6% |
| Renal Tubular Disorder |
2.6% |
| Syncope |
2.6% |
| Ulcer |
2.6% |
|
| Concomitant |
| Hepatitis B |
32.8% |
| Chronic Hepatitis B |
13.6% |
| Hiv Infection |
8.0% |
| Hepatic Neoplasm Malignant |
7.2% |
| Ascites |
4.8% |
| Hepatic Cirrhosis |
4.8% |
| Anxiety Disorder |
3.2% |
| Non-small Cell Lung Cancer |
3.2% |
| Product Used For Unknown Indication |
3.2% |
| Hepatic Function Abnormal |
2.4% |
| Varices Oesophageal |
2.4% |
| Diabetes Mellitus |
1.6% |
| Hepatic Cancer Metastatic |
1.6% |
| Hyperammonaemia |
1.6% |
| Hypertension |
1.6% |
| Liver Transplant |
1.6% |
| Type 2 Diabetes Mellitus |
1.6% |
| Viral Infection |
1.6% |
| Vulvovaginal Candidiasis |
1.6% |
| Vulvovaginal Dryness |
1.6% |
|
| White Blood Cell Count Increased |
11.1% |
| Blood Creatinine Increased |
7.4% |
| Hepatic Neoplasm Malignant Recurrent |
7.4% |
| Rhabdomyolysis |
7.4% |
| Thrombocytopenia |
7.4% |
| Weight Decreased |
7.4% |
| Asthenia |
3.7% |
| Blood Albumin Decreased |
3.7% |
| Blood Glucose Increased |
3.7% |
| Chest Pain |
3.7% |
| Diarrhoea |
3.7% |
| Dry Eye |
3.7% |
| Dyspnoea |
3.7% |
| Foetal Death |
3.7% |
| Hepatic Function Abnormal |
3.7% |
| Hepatic Neoplasm Malignant |
3.7% |
| Liver Function Test Abnormal |
3.7% |
| Liver Transplant Rejection |
3.7% |
| Myalgia |
3.7% |
| Myositis |
3.7% |
|
